RUBY
NASDAQRubius Therapeutics Inc.
Latest news
25 items- SECSEC Form 15-12G filed by Rubius Therapeutics Inc.15-12G - Rubius Therapeutics, Inc. (0001709401) (Filer)
- 13D/GSEC Form SC 13G/A filed by Rubius Therapeutics Inc. (Amendment)SC 13G/A - Rubius Therapeutics, Inc. (0001709401) (Subject)
- SECRubius Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Rubius Therapeutics, Inc. (0001709401) (Filer)
- SECSEC Form 25 filed by Rubius Therapeutics Inc.25 - Rubius Therapeutics, Inc. (0001709401) (Filer)
- SECSEC Form DEF 14A filed by Rubius Therapeutics Inc.DEF 14A - Rubius Therapeutics, Inc. (0001709401) (Filer)
- NEWSStocks That Hit 52-Week Lows On MondayOn Monday, 36 companies set new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was Sirius XM Holdings (NASDAQ:SIRI). The smallest company by market cap to set a new 52-week low was Altamira Therapeutics (NASDAQ:CYTO). China Pharma Holding (AMEX:CPHI) saw the most significant move of the companies, as shares traded down 871.52% to reach its new 52-week low. VEON (NASDAQ:VEON) shares rebounded the highest, with shares trading up 0.0%, bouncing back after reaching its new 52-week low. Stocks dropping to new 52-week lows on Monday: Sirius XM Holdings (NASDAQ:SIRI) shares fell to $4.20 on Monday, setting a new 5
- NEWSWhy Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day SessionGainers Unicycive Therapeutics, Inc. (NASDAQ:UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb. BridgeBio Pharma, Inc. (NASDAQ:BBIO) shares jumped 59.5% to $17.34 after the company announced positive data for its phase 2 study of Infigratinib in Achondroplasia. Avalon GloboCare Corp. (NASDAQ:ALBT) shares gained 53.5% to $3.3330. Azul S.A. (NYSE:AZUL) gained 45.3% to $6.05 after the company announced a deal to reduce the immediate cash it must expend for leased property. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) rose 28.3% to $21.49. HC Wainwright & Co. maintained Kala Pharmac
- NEWS12 Health Care Stocks Moving In Monday's Intraday SessionGainers Unicycive Therapeutics (NASDAQ:UNCY) stock moved upwards by 151.2% to $1.23 during Monday's regular session. Trading volume for this security as of 12:30 EST is 77.1 million, which is 22303.6% of its average full-day volume over the last 100 days. The company's market cap stands at $18.5 million. Bellerophon Therapeutics (NASDAQ:BLPH) stock increased by 82.49% to $3.3. Bellerophon Therapeutics's stock is trading at a volume of 11.1 million shares as of 12:30 EST. This is 1023.2% of its average full-day volume over the last 100 days. The company's market cap stands at $31.4 million. BridgeBio Pharma (NASDAQ:BBIO) stock rose 58.0% to $17.18. Trading volume for BridgeBio Pharma's sto
- NEWS12 Health Care Stocks Moving In Monday's Pre-Market SessionGainers Unicycive Therapeutics (NASDAQ:UNCY) shares increased by 114.3% to $1.05 during Monday's pre-market session. The company's market cap stands at $15.8 million. BridgeBio Pharma (NASDAQ:BBIO) stock moved upwards by 56.39% to $17.0. The market value of their outstanding shares is at $2.5 billion. vTv Therapeutics (NASDAQ:VTVT) stock increased by 48.51% to $1.2. The company's market cap stands at $97.7 million. Kala Pharmaceuticals (NASDAQ:KALA) shares increased by 27.46% to $21.35. The company's market cap stands at $39.9 million. The company's, Q4 earnings came out yesterday. TCR2 Therapeutics (NASDAQ:TCRR) shares rose 25.61% to $1.52. The market value of their outstanding shares
- NEWSWhy Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving PremarketGainers Secoo Holding Limited (NASDAQ:SECO) rose 44% to $1.44 in pre-market trading after dipping over 31% on Friday. Entera Bio Ltd. (NASDAQ:ENTX) rose 43.1% to $1.46 in pre-market trading after dropping 5% on Friday. Entera Bio recently announced the FDA's acceptance of a Type D meeting review to affirm design of the pivotal, Phase 3 protocol for EB613 PTH mini tablets, as the first oral osteoanabolic treatment of post-menopausal osteoporosis. BuzzFeed, Inc. (NASDAQ:BZFD) rose 20.7% to $1.87 in pre-market trading. BuzzFeed is expected to release its Q4 financial results on Monday, March 13, 2023, after the closing bell. BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) rose 12.5% to $2.8
- NEWSWhy Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day SessionGainers ObsEva SA (NASDAQ:OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares jumped 52.7% to $3.59 after the company said data from a recent peer-reviewed clinical study demonstrated Bentrio's superior nasal residence time and rheological properties. Lavoro Limited (NASDAQ:LVRO) gained 44.7% to $13.86. Lavoro and TPB Acquisition Corporation I announced completion of business combination. HUB Cyber Security (Israel) Ltd. (NASDAQ:HUBC) rose 36.6% to $1.71 after dipping 21% on Thursday. Seer, Inc. (NASDAQ:SEER) gained 35% to $5.68 a
- 13D/GSEC Form SC 13G/A filed by Rubius Therapeutics Inc. (Amendment)SC 13G/A - Rubius Therapeutics, Inc. (0001709401) (Subject)
- NEWSWhy Heritage Insurance Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving PremarketGainers ObsEva SA (NASDAQ:OBSV) rose 93.1% to $0.2047 in pre-market trading after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) rose 53.1% to $4.18 in pre-market trading. Bullfrog AI recently priced its IPO at $6.50 per share. Rubius Therapeutics, Inc. (NASDAQ:RUBY) rose 28.7% to $0.1461 in pre-market trading. Rubius Therapeutics recently outlined dissolution plan, after unsuccessful attempt on alternatives. Smart for Life, Inc. (NASDAQ:SMFL) rose 19.7% to $0.2278 in pre-market trading. Smart for Life is scheduled to hold shareholder meeting on March 15, 2023. HUB Cyb
- NEWS12 Health Care Stocks Moving In Friday's Pre-Market SessionGainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 47.6% to $4.03 during Friday's pre-market session. The company's market cap stands at $22.7 million. Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 31.71% to $0.15. The company's market cap stands at $13.5 million. Ardelyx (NASDAQ:ARDX) shares rose 17.3% to $3.39. The market value of their outstanding shares is at $673.1 million. The company's, Q4 earnings came out yesterday. Akari Therapeutics (NASDAQ:AKTX) shares rose 16.24% to $0.38. The market value of their outstanding shares is at $28.2 million. Milestone Scientific (AMEX:MLSS) shares rose 13.92% to $0.9. The company's market cap stands at $62.8 million. Confor
- SECSEC Form PRER14A filed by Rubius Therapeutics Inc.PRER14A - Rubius Therapeutics, Inc. (0001709401) (Filer)
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers Reata Pharmaceuticals (NASDAQ:RETA) stock moved upwards by 178.0% to $86.65 during Wednesday's regular session. The current volume of 10.1 million shares is 1012.6% of Reata Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $3.1 billion. OncoSec Medical (NASDAQ:ONCS) stock moved upwards by 92.59% to $2.08. Trading volume for this security as of 12:30 EST is 58.4 million, which is 7655.3% of its average full-day volume over the last 100 days. The company's market cap stands at $6.1 million. BiomX (AMEX:PHGE) stock increased by 48.84% to $0.6. Trading volume for BiomX's stock is 1.7 millio
- INSIDERSEC Form 4: Appelhans Dannielle sold $1,323 worth of shares (10,385 units at $0.13), closing all direct ownership in the company4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
- NEWSWhy Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday's Mid-Day SessionGainers Lucira Health, Inc. (NASDAQ:LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test. ContraFect Corporation (NASDAQ:CFRX) shares jumped 66% to $5.14. ObsEva SA (NASDAQ:OBSV) jumped 56.5% to $0.1299. ObsEva shares dropped over 50% on Friday after the company announced strategic reorganization to consolidate operations in Switzerland. Blackboxstocks Inc. (NASDAQ:BLBX) rose 33% to $0.7300. Blackboxstocks said it sees Q4 revenue of $950K-$1.05M. Moolec Science SA (NASDAQ:MLEC) gained 25.3% to $5.14. AERWINS Technologies Inc. (NASDAQ:AWIN) shares rose 24.5% to $2.0909 after gaining more than 10% on Friday. Fisker
- SECSEC Form PRE 14A filed by Rubius Therapeutics Inc.PRE 14A - Rubius Therapeutics, Inc. (0001709401) (Filer)
- NEWS12 Health Care Stocks Moving In Monday's Pre-Market SessionGainers Lucira Health (NASDAQ:LHDX) shares moved upwards by 217.8% to $0.44 during Monday's pre-market session. The company's market cap stands at $18.0 million. UpHealth (NYSE:UPH) shares moved upwards by 36.73% to $2.68. The company's market cap stands at $40.3 million. ContraFect (NASDAQ:CFRX) shares moved upwards by 32.9% to $4.12. The company's market cap stands at $2.2 million. Virax Biolabs Group (NASDAQ:VRAX) shares increased by 24.61% to $0.8. The company's market cap stands at $10.2 million. Sangamo Therapeutics (NASDAQ:SGMO) stock increased by 19.01% to $3.16. The market value of their outstanding shares is at $532.3 million. As per the news, the Q4 earnings report came out 3
- SECSEC Form 10-K filed by Rubius Therapeutics Inc.10-K - Rubius Therapeutics, Inc. (0001709401) (Filer)
- SECSEC Form S-8 POS filed by Rubius Therapeutics Inc.S-8 POS - Rubius Therapeutics, Inc. (0001709401) (Filer)
- SECSEC Form S-8 POS filed by Rubius Therapeutics Inc.S-8 POS - Rubius Therapeutics, Inc. (0001709401) (Filer)
- SECSEC Form S-8 POS filed by Rubius Therapeutics Inc.S-8 POS - Rubius Therapeutics, Inc. (0001709401) (Filer)
- SECSEC Form S-8 POS filed by Rubius Therapeutics Inc.S-8 POS - Rubius Therapeutics, Inc. (0001709401) (Filer)
RUBY FAQ
7 questionsWhat does Rubius Therapeutics Inc. do?
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of cancer; and RTX-aAPC to treat solid and hematological cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.Where does RUBY stock trade?
Rubius Therapeutics Inc. (RUBY) is listed on NASDAQ.What sector and industry is RUBY in?
Rubius Therapeutics Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Rubius Therapeutics Inc. go public?
Rubius Therapeutics Inc. (RUBY) completed its IPO in 2018.What are analysts saying about RUBY?
Rubius Therapeutics Inc. has had 4 recent analyst actions on file. The most recent action was from Guggenheim: Neutral on 2022-09-13. Recent price targets range from $500.00 to $2200.00.What companies are similar to RUBY?
Notable peers in the same industry include RPTX (Repare Therapeutics Inc.), HARP (Harpoon Therapeutics Inc.), APLT (Applied Therapeutics Inc.), MCRB (Seres Therapeutics Inc.), ATHE (Alterity Therapeutics Limited). Compare RUBY side-by-side with any of them on Quantisnow.How can I track RUBY on Quantisnow?
Quantisnow aggregates Rubius Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RUBY to receive live email and push alerts on every new disclosure.